Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts

Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts

US Patent 7189853 · Granted Mar 13, 2007

Estimated economic value: $3,321,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for the preparation of (1S, 4S, 7Z, 10S, 16E, 21R)-7-ethyldene-4,21-bis(2020
Processes for the preparation of AZD5363 and intermediate used therein2018
Process for the preparation of triazole antifungal drug, its intermediates and p2015
Process for the preparation of benzimidazole derivatives and its salts2015
Process for statins and its pharmaceutically acceptable salts thereof2013
Process for the preparation of statins and their pharmaceutically acceptable sal2013
Process for pure duloxetine hydrochloride2013
Process for the preparation of Montelukast and its pharmaceutically acceptable s2012
Process for preparing (2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-2011
Amorphous form of 3-[2-(dimethylamino) ethyl]-N-methyl-1H-indole-5-methane sulfo2006
Stable arylpyrrole particles, process for their preparation and suspension conce2002
Stable arylpyrrole particles, process for their preparation and suspension conce2001